| Literature DB >> 32232179 |
Abdul Qader Tahir Ismail1,2, Elaine M Boyle1, Thillagavathie Pillay2,3.
Abstract
OBJECTIVE: There is evidence that birth and care in a maternity service associated with a neonatal intensive care unit (NICU) is associated with improved survival in preterm babies born at <27 weeks of gestation. We conducted a systematic review to address whether similar gains manifested in babies born between 27+0 and 31+6 weeks (hereafter 27 and 31 weeks) of gestation, or in those with a birth weight between 1000 and 1500 g.Entities:
Keywords: evidence based medicine; health service; neonatology
Year: 2020 PMID: 32232179 PMCID: PMC7101044 DOI: 10.1136/bmjpo-2019-000583
Source DB: PubMed Journal: BMJ Paediatr Open ISSN: 2399-9772
International summary of organisation of neonatal care services, extracted from national guidelines and relevant reviews
| Level 1 | Level 2 | Level 3 | |
| USA | Care for babies born | Care for babies born Stabilise babies born <32 weeks or <1500 g, and brief periods of mechanical ventilation, before transfer to a NICU | Level 3 NICU care for babies of all gestational ages and birth weight Level 4 regional NICU have level 3 capabilities and are located within an institution with surgical and paediatric medical capabilities |
| Canada | Tier 1a care for babies ≥37 weeks and ≥2500 g Tier 1b care for babies ≥35 weeks and ≥1800 g | Tier 2a care for babies ≥32 weeks and ≥1500 g Tier 2b care for babies ≥30 weeks and ≥1200 g | Tier 3 care for babies of all gestational ages and birth weight with non-life-threatening conditions Tier 4 provide tier 3 services to babies of all gestational ages and birth weight, including those with life-threatening conditions and requiring paediatric subspecialty input |
| Australia | Previously labelled level one now includes level 1, 2 and 3 Level 1 and 2 do not provide routine neonatal care Level 3 care for babies >36/ | Previously labelled level 2a and 2b now includes level 4 and 5 Level 4 care for babies >32/ Level 5 care for babies >31/ | Previously labelled level 3 now includes level 6 Care for babies of all gestational ages and birth weight, including surgery and congenital and metabolic diseases May be split into 6a and 6b, with only the latter providing surgical and specialty services |
| New Zealand | Care for babies >36 weeks | Care for babies >32 weeks Some units (level 2+) care for babies >28 weeks | Care for babies of all gestational ages and birth weight |
| Finland | Smaller, non-university hospitals provide care to babies >32 weeks and >1500 g | University hospitals care for babies of all gestational ages and birth weight | |
| Sweden | Smaller, non-regional centres provide care to babies >28 weeks | Regional centres care for babies of all gestational ages and birth weight | |
| France | No neonatal ward Not required to have a paediatrician on-site | Care for babies >32 weeks Paediatrician must be present during the day, can be on-call at nights and weekends | Care for babies of all gestational ages and birth weight Neonatologist must always be present |
NICU, neonatal intensive care unit.
Summary of differences between three levels of neonatal care within the UK, adapted from British Association of Perinatal Medicine61 62
| Level 1 (special care unit—SCU) | Level 2 (local neonatal unit—LNU) | Level 3 (neonatal intensive care unit—NICU) |
Care for babies born Provide special care and may provide some high dependency care. Stabilise babies who need to be transferred to an LNU or NICU. Receive transfers from units within their network for continuing special care. Doctors and nursing staff are on a shared rota with paediatric services. Consultants are general paediatricians. | Care for babies born Provide all categories of care for their local population (including short periods of intensive care), but transfer babies requiring complex or longer-term intensive care to a NICU. Depending on size and level of activity, doctors and nursing staff may be on a shared or separate rota with paediatric services. Some consultants have neonatal expertise, while others are general paediatricians. | Care for babies of all gestational ages (>22/23 weeks). Sited alongside specialist obstetric and fetomaternal services. Provide all categories of neonatal care (including non-conventional modes of ventilation, inhaled nitric oxide, and therapeutic hypothermia). May be colocated with surgery and other specialised services. Consulted for advice and receive transfers from other units within their network. Doctors and nursing staff are not on a shared rota with paediatric services. All consultants have neonatal expertise. |
Figure 1Flow diagram showing results from systematic review search strategy for studies categorising neonates by gestational age and birth weight. *Miscellaneous include studies excluded due to comparing outcomes in NICU versus NICU/a geographical area/paediatric hospitals/neonatal care in a non-regionalised healthcare system; studies investigating degree of regionalisation/incidence and avoidability of ex utero transfers; and studies comparing birth asphyxia in term infants/success of using early nasal CPAP. BW, birth weight; CPAP, continuous positive airway pressure; NICU, neonatal intensive care unit.
Study characteristics and outcomes for studies characterising neonates by gestational age and birth weight
| Categorisation method | Type of study (comparator groups) | Study | Country of study | Total number of babies | Population (gestation (weeks +days)/birth weight (g)) | Outcomes reported by included studies | ||||||||
| Mortality timeframe | Survival timeframe | Morbidity | ||||||||||||
| Undefined | Perinatal | Neonatal | Discharge | Infant | 2 years | Discharge | 2 years | |||||||
| Gestational age | Lamont | UK | 206 | 28+0–29+6 | Non-significant difference in incidence of IVH. | |||||||||
| 30+0–31+6 | Significant reduction in incidence of IVH. | |||||||||||||
| Truffert | France | 157 | 27+0–30+6 | Non-significant difference in incidence of survival (up to 2 years of age) without disability.* | ||||||||||
| Hauspy | Belgium | 315 | 28+0–29+6 | Non-significant difference in incidence of RDS. | ||||||||||
| 30+0–31+6 | ||||||||||||||
| Lee | Canada | 2148 | 27+0–29+6 | Non-significant difference in incidence of IVH, NEC and ROP. | ||||||||||
| 30+0–31+6 | Non-significant difference in incidence of IVH, NEC, ROP and CLD. | |||||||||||||
| Boland | Australia | 250 | 28+0–31+6 | No other outcomes measured. | ||||||||||
| Level of unit of birth (NICU vs non-NICU) | Holmgren and Högberg | Sweden | 394 | 28+0–31+6 | Non-significant difference in incidence of asphyxia† | |||||||||
| Johansson | Sweden | 1636 | 28+0–31+6 | No other outcomes measured. | ||||||||||
| Level of unit of care (NICU vs non-NICU) | Field | UK | 171 | 29+0–30+6 | No other outcomes measured. | |||||||||
| Jonas and Lumley | Australia | 3331 | 28+0–31+6 | No other outcomes measured. | ||||||||||
| Birth weight | Miller | USA | 94 | 1000–1500 | No other outcomes measured. | |||||||||
| Watkinson and McIntosh | UK | 154 | 1001–1500 | No other outcomes measured. | ||||||||||
| Powell and Pharoah | UK | 390 | 1000–1500 | No other outcomes measured. | ||||||||||
| Obladen | Germany | 220 | 1000–1249 | Non-significant difference in incidence of IVH. | ||||||||||
| 1250–1499 | No other outcomes measured. | |||||||||||||
| Mohamed and Aly | USA | 36 493 | 1000–1500 | Significant reduction in incidence of IVH. | ||||||||||
| Level of unit of birth (NICU vs non-NICU) | Gortmaker | USA | 4874 | 1000–1500 | No other outcomes measured. | |||||||||
| Powell | USA | 947 | 1000–1500 | No other outcomes measured. | ||||||||||
| Yeast | USA | 2852 | 1000–1500 | No other outcomes measured. | ||||||||||
| Sanderson | USA | 1345 | 1000–1249 | No other outcomes measured. | ||||||||||
| 1250–1499 | No other outcomes measured. | |||||||||||||
| Gould | USA | undefined (<4405) | 1000–1500 | No other outcomes measured. | ||||||||||
| Warner | USA | 474 | 1000–1500 | Non-significant difference in incidence of NEC (Bell stage II or III) or death. | ||||||||||
denotes direction of significant difference found between comparator groups (first comparator vs second comparator), and NS denotes lack of significant difference between comparator groups). For example, Jonas 1997 showed a significantly lower (arrow in downward direction) neonatal mortality for those babies born between 28+0 and 31+6 in a NICU (first comparator) versus a non-NICU (second comparator).
*Disability is a composite outcome measure consisting of cerebral palsy, deafness, Brunet-Lézine developmental score <80.63
†Asphyxia refers to Apgar score <5 at 10 min of age.
BPD, bronchopulmonary dysplasia; CLD, chronic lung disease; IVH, intraventricular haemorrhage; NEC, necrotising enterocolitis; NICU, neonatal intensive care unit; RDS, respiratory distress syndrome; ROP, retinopathy of prematurity.
Assessment of study quality (categorising babies by gestational age) using modified QUIPS tool (for in-depth analysis, see online supplementary tables S1 and S2)
| Type of study (comparator groups) | Study | Criteria of modified QUIPS tool | ||||
| Study participation (population, exclusion criteria, comparison of baseline characteristics between comparator groups) | Study attrition (prospective or retrospective, data source, completeness of data on demographic/confounding factors, proportion of babies outcome analysis carried out on) | Prognostic factor measurement (definition of birth location, explanation of facilities available at different level units) | Outcome measurement (definition) | Study confounding (adjustment for confounding factors, which variables used) | ||
| Lamont | ||||||
| Truffert | ||||||
| Hauspy | ||||||
| Lee | ||||||
| Boland | ||||||
| Level of unit of birth (NICU vs non-NICU) | Holmgren and Högberg | |||||
| Johansson | ||||||
| Level of unit of care (NICU vs non-NICU) | Field | |||||
| Jonas and Lumley | ||||||
✓ denotes adequate quality, and x indicates inadequate quality.
NICU, neonatal intensive care unit; QUIPS, QUality In Prognostic Studies.